Latest Product Innovation News

Challenger Limited reported a robust first half of FY25 with a 12% rise in normalized NPAT and a 12% increase in its interim dividend, driven by strong annuity sales and strategic technology investments.

Challenger Limited has reported a robust first half of FY25, with a 12% increase in normalized NPAT and significant strides in annuity sales and technology modernization, positioning the company for sustained growth.

Challenger Limited posted a robust first half of FY25, with normalised net profit after tax rising 12% to $225 million, underpinned by strong Life and Funds Management segments despite softer annuity sales. The company maintains a confident outlook for FY25, forecasting further profit growth.

Challenger Limited reported a robust 12% increase in normalized NPAT to $225 million for 1H25, underpinned by strong earnings, dividend growth, and strategic investments in technology and distribution channels.

Simonds Group delivered a resilient $13.6 million EBITDA in 1H FY25 amid a soft residential market and announced a strategic acquisition of Dennis Family Homes to fuel future growth.

Vection Technologies has inked a three-year SaaS agreement with Mexican telecom giant Totalplay, marking a strategic push into Latin America with its Enworks XR platform.

GWA Group Limited reported a 1.9% revenue increase and a 3.2% rise in normalized EBIT for the half year ended December 2024, alongside a 7.1% lift in its interim dividend, reflecting disciplined execution despite tough market conditions.

The a2 Milk Company posted robust first-half FY25 results, lifting revenue by 10.1% and net profit by 7.6%, while introducing a dividend policy for the first time. Strong English label IMF sales and liquid milk growth underpin an upgraded full-year outlook.

The a2 Milk Company delivered solid first-half FY25 results with revenue up 10.1% and net profit rising 7.6%, driven by strong growth in China and the USA despite supply constraints and ANZ challenges. The company also declared its first-ever interim dividend and upgraded its full-year outlook.

The a2 Milk Company has reported robust first-half FY25 results, boosting full-year guidance and declaring its inaugural dividend, underscoring confidence in its growth trajectory.

Cochlear Limited posted a 6% increase in HY25 sales revenue driven by strong implant sales but anticipates FY25 profits at the lower end of guidance due to declining services revenue and rising cloud investments.

Cochlear Limited has reported a robust half-year performance with a 7% increase in underlying net profit and an 8% rise in interim dividends, driven by strong sales in cochlear and acoustic implants despite a decline in services revenue.